Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-011712
Filing Date
2017-11-09
Accepted
2017-11-09 19:02:40
Documents
1
Period of Report
2017-11-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4110717macaluso_aytubio.html 4  
1 OWNERSHIP DOCUMENT f4110717macaluso_aytubio.xml 4 3488
  Complete submission text file 0001213900-17-011712.txt   5112
Mailing Address C/O AMPIO PHARMACEUTICALS, INC. 5445 DTC PARKWAY, SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address
MACALUSO MICHAEL (Reporting) CIK: 0001096423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 171192398

Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations